News
- A Pediatric Cancer Drug Three Decades in the Making
- Discovery to Commercialization: New Immunotherapy for Rare Childhood Cancer, Neuroblastoma
Leadership
John Yu, M.D., Ph.D.
Alice Yu, M.D., Ph.D.
Jung-Tung Hung, Ph.D.
Maintainer: Ko Ching
Update: 2017.11.28